Article
Lilly's blockbuster Mounjaro boosts third quarter results, supply issues persist
Rating:
0.0
Views:
51
Likes:
1
Library:
1
Surging demand for Eli Lilly's diabetes drug Mounjaro, which is also being used off-label for weight loss, led to a surprise third-quarter profit, but the drugmaker on Thursday said it expects supply constraints for some time as it adds manufacturing capacity.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value